Johnson & Johnson starts Phase 3 trial with single-dose coronavirus vaccine.

Johnson & Johnson starts Phase 3 trial with single-dose coronavirus vaccine.: Multiple vaccines will likely be required to vaccinate billions of people to sufficiently suppress the virus.